Cargando…
Serum microRNA-592 serves as a novel potential biomarker for early diagnosis of colorectal cancer
Colorectal cancer (CRC) is the second leading cause of cancer-associated mortality worldwide. Currently, available diagnostic biomarkers are neither sensitive nor specific. Thus, the present study aimed to identify novel circulating microRNAs (miRNAs) as biomarkers for the early diagnosis of CRC. Al...
Autores principales: | Pan, Zhenguo, Miao, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377022/ https://www.ncbi.nlm.nih.gov/pubmed/32724351 http://dx.doi.org/10.3892/ol.2020.11682 |
Ejemplares similares
-
MicroRNA-592 promotes cell proliferation, migration and invasion in colorectal cancer by directly targeting SPARC
por: Pan, Zhenguo, et al.
Publicado: (2021) -
Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease
por: Dong, Hui, et al.
Publicado: (2015) -
Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma
por: Zheng, G, et al.
Publicado: (2014) -
MicroRNA-592 serves as a novel tumor suppressor in Uveal melanoma: bioinformatics analysis and in vitro cell function verification
por: Lei, Peng, et al.
Publicado: (2023) -
A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis
por: Li, Rongkang, et al.
Publicado: (2023)